Welcome back. In this edition of the Corner I wanted to provide a recent update relating to screening for hepatitis C.
I am sure everyone is aware of the advancements in treatment of hepatitis C that Read More »
Welcome back. In this edition of Ron’s Clinical Corner, I would like to give a brief overview and update on new advances in the treatment of cystic fibrosis.
Cystic fibrosis (CF) is a genetic disorder characterized Read More »
Welcome back everyone, I hope you had a wonderful holiday season and best wishes for a safe and happy new year.
In this edition of Ron’s Clinical Corner, I want to provide you with some of Read More »
Welcome back to the Corner. With all the buzz surrounding the most recent ranitidine recall I thought it may be a good time to talk about drug recalls.
Unfortunately, it is common for product recalls to Read More »
In this edition of Ron’s Clinical Corner, I will be discussing new treatment options for the management of peanut allergies in children and adolescents.
It is estimated that approximately 1.25 million children and adolescents in the Read More »
Welcome back to the Corner. With students back to school and the fall season upon us, I thought it would be a good opportunity to talk about the flu.
Everyone is aware that the flu is Read More »
Hello again, I hope everyone is enjoying the summer season. I thought it would be fitting for this time of year to talk about how certain medications can cause individuals to be more sensitive to Read More »
Welcome back. In this issue, we are going to discuss a recent rule set forth regarding drug pricing featured in television advertisements.
In May 2019, the U.S. Department of Health and Human Services (HHS) issued a Read More »
Welcome back to the Clinical Corner. In this issue, we will touch on new FDA requirements, focused on the labeling for opioid products.
It is common knowledge that the opioid crisis and epidemic continues to be Read More »
Welcome back to the Clinical Corner. In this issue, I would like to provide you with an update on a few new medications that have been approved for the treatment of Multiple Sclerosis (MS).
In late Read More »